Iceland Pharmaceutical and Medical Goods Expenditure Share (2024)
Iceland's Pharmaceutical and Medical Goods Expenditure Share: 14.6 % of current health expenditure in 2024, unchanged YoY.
Iceland (2024)
14.6
% of current health expenditure
unchanged YoY
YoY Change
unchanged
percentage points
Trend
neutral
Series length
9
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 14.6 | unchanged |
| 2023 | 14.6 | +1.4pp |
| 2022 | 13.2 | -0.9pp |
| 2021 | 14.1 | +0.3pp |
| 2020 | 13.8 | +0.3pp |
| 2019 | 13.5 | +0.3pp |
| 2018 | 13.2 | -0.2pp |
| 2017 | 13.4 | -0.6pp |
| 2016 | 14 | n/a |
About this Dataset
Iceland recorded 14.6 % of current health expenditure in 2024. That is unchanged on the previous period. Across 2016–2024 the series ranges from 13.2 in 2018 to 14.6 in 2023.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Iceland.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Iceland. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2016–2024 (9 observations).
The series peaked at 14.6 % of current health expenditure in 2023 and reached its lowest recorded value of 13.2 in 2018. The latest reading of 14.6 in 2024 is unchanged on the previous period.